New pill GEN-725 enters early human testing for advanced cancers
NCT ID NCT07229898
First seen Nov 17, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This early-phase study tests a new tablet called GEN-725 in 48 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants must be between 18 and 75 years old and have no other standard options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital)
RECRUITINGJinan, China
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, China
-
Shanghai East Hospital
RECRUITINGShanghai, China
-
The First Affiliated Hospital of Xinxiang Medical University
RECRUITINGXinxiang, China
Conditions
Explore the condition pages connected to this study.